Literature DB >> 17512685

Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b.

M Hamidi1, A H Zarrin, M Foroozesh, N Zarei, S Mohammadi-Samani.   

Abstract

Carrier erythrocytes is one of the most promising systemic drug delivery systems investigated in recent decades. In this study, human erythrocytes have been loaded with interferon-alpha 2b (IFN) with the aim to benefit the reticuloendothelial system (RES) targeting potential of the carrier cells. Hypotonic preswelling method was used for drug loading in erythrocytes and the entire loading procedure was evaluated and validated. The loaded amount, entrapment efficiency and cell recovery of the loading procedure were 2906.33+/-588.35IU/0.1ml, 14.53+/-2.94%, and 83.61+/-0.49%, respectively, all being practically feasible. The carrier erythrocytes were characterized in vitro in terms of their drug release kinetics, hematological indices, particle size distribution, SEM analysis, and osmotic and turbulence fragility. IFN release from carrier cells was a relatively rapid process in comparison to the cell lysis kinetics, which is unusual considering the whole body of data published on this delivery system and other protein drugs, so far. All the tested in vitro characteristics showed significant, sometimes notable changes upon drug loading procedure, both with and without the drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512685     DOI: 10.1016/j.ijpharm.2007.04.001

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel.

Authors:  Gamaleldin I Harisa; Mohamed F Ibrahim; Fars Alanazi; Gamal A Shazly
Journal:  Saudi Pharm J       Date:  2013-01-07       Impact factor: 4.330

2.  Simulation of the osmosis-based drug encapsulation in erythrocytes.

Authors:  Duobiao Ge; Lili Zou; Chengpan Li; Sen Liu; Shibo Li; Sijie Sun; Weiping Ding
Journal:  Eur Biophys J       Date:  2017-09-20       Impact factor: 1.733

3.  Engineering of erythrocyte-based drug carriers: control of protein release and bioactivity.

Authors:  Rongcong Luo; Shaillender Mutukumaraswamy; Subbu S Venkatraman; Björn Neu
Journal:  J Mater Sci Mater Med       Date:  2011-11-18       Impact factor: 3.896

4.  Cyclic arginine-glycine-aspartic acid-modified red blood cells for drug delivery: Synthesis and in vitro evaluation.

Authors:  Chen Wang; Min Wang; Yan Zhang; Hongxin Jia; Binbin Chen
Journal:  J Pharm Anal       Date:  2021-06-12

5.  Characterization of human erythrocytes as potential carrier for pravastatin: an in vitro study.

Authors:  Gamal El-din I Harisa; Mohamed F Ibrahim; Fars K Alanazi
Journal:  Int J Med Sci       Date:  2011-03-11       Impact factor: 3.738

Review 6.  Drug-loaded erythrocytes: on the road toward marketing approval.

Authors:  Vanessa Bourgeaux; José M Lanao; Bridget E Bax; Yann Godfrin
Journal:  Drug Des Devel Ther       Date:  2016-02-11       Impact factor: 4.162

7.  Red Blood Cells are Appropriate Carrier for Coagulation Factor VIII.

Authors:  Fatemeh Sayyadipour; Naser Amirizadeh; Arezoo Oodi; Masoud Khalili; Fakhredin Saba
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2020

8.  Assessment of red blood cell deformability in type 2 diabetes mellitus and diabetic retinopathy by dual optical tweezers stretching technique.

Authors:  Rupesh Agrawal; Thomas Smart; João Nobre-Cardoso; Christopher Richards; Rhythm Bhatnagar; Adnan Tufail; David Shima; Phil H Jones; Carlos Pavesio
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.